NSABP于1985年公布结果如下:在腋淋巴结临床阴性的乳腺癌患者中,RM、TMR和TM三组的无瘤生存率(简称DFS)、无远处转移生存率(简称DDFS)和总生存率(简称OS)无显著性差异;在腋淋巴结阳性的乳腺癌患者中,RM和TMR的DFS、DDFS和OS也无显著性差异。同时,乳腺肿瘤的发生位置不影响病人的预后,肿瘤位于乳头内侧病人行内乳...
Gradishar, MD; David Cella, PhD JAMA Original Contribution Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention Stephanie R. Land, PhD; D. Lawrence Wickerham, MD; Joseph P. Costantino, DrPH; Marcie W. Ritter, PhD; Victor G....